Please login to the form below

Fishawack acquires creative consultancy Blue Latitude Health

The Fishawack Group has acquired Blue Latitude Health, based in London, UK, and New York, USA. Blue Latitude Health is a creative consultancy combining the commercial focus of a consultancy with the creative vision of an agency.

The Fishawack Group of Companies, one of the world’s largest independent medical communications and medical marketing organizations, has acquired Blue Latitude Health, based in London, UK, and New York, USA. Blue Latitude Health is a creative consultancy combining the commercial focus of a consultancy with the creative vision of an agency.

“In 2016, we set out our vision to form a major new force in the global creative agency space that would make us as strong in the creative arena as we already are in medical communications,” explained Oliver Dennis, Chief Executive Officer of the Fishawack Group. “With three acquisitions in this space in the last 16 months, I think we’ve firmly announced our intention to achieve this goal. We were actively looking for a consultancy that could bring strategic and customer experience expertise to our portfolio and Blue Latitude Health fits perfectly.”

“To enable us to continue to grow and provide existing and future clients with a stronger offering, we needed to find a partner who both shared our values and matched our ambition,” stated Martin Brass, Managing Director of Blue Latitude Health. “We believe we have found this partner in Fishawack.”

Fred Bassett, Head of Strategy and Co-founder of Blue Latitude Health, added “We are thrilled to join an organization with the global scale and extended services in medical and scientific communications that Fishawack offers.”

“Many of our clients are wanting a partner that has specialist global capabilities both commercially and medically, and can ensure alignment of communication objectives,” commented Gail Flockhart, Group Managing Director of Fishawack. “Blue Latitude Health has a deep strategic consulting capability and brings us a base in New York City, from which we can continue to expand our East Coast creative and medical communications teams.”

Fishawack received corporate finance and legal support from Rick Stark and Phil Hall of KPMG, and George Danczak and James Finney of Addleshaw Goddard LLP (UK), respectively.

Photo: Dominic Miller, Fred Bassett, Oliver Dennis (back row from left to right), Martin Brass, Gail Flockhart (front row from left to right).

19th December 2018

Share

Tags

Company Details

Fishawack Health

+44 20 3328 1840

Contact Website

Address:
No. 3 Booths Park
Booths Hall
Chelford Road
Knutsford
Cheshire
WA16 8GS
United Kingdom

Latest content on this profile

Fishawack Health expands its value, evidence, and market access capabilities with the acquisition of HEOR consultancy Policy Analysis Inc. (PAI)
Fishawack Health announces its expanded global Value, Evidence, and Access (VEA) capability for biopharmaceutical and medical technology companies, with a suite of end-to-end services spanning product lifecycle, coupled with unsurpassed geographic reach.
Fishawack Health
What’s the top trend uniting patients, healthcare professionals, and payers? The desire for a connected customer experience
Milo Elmir, Managing Consultant, examines the trends changing the behaviors of 3 healthcare stakeholders—patients, payers, and healthcare professionals—and explores how building human-centered solutions will help biopharmaceutical and medical technology companies drive better engagement.
Fishawack Health
6 critical success factors for flawless execution of a rapid first commercial launch
Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline.
Fishawack Health
How to innovate and influence people in times of misinformation
The pandemic has shown that public trust in promising new medical technologies is far from a given. Senior Writer Tom Vandyck at StoneArch, a member of Fishawack delves into the right approach to help companies with breakthrough innovations in their pipeline build consumer confidence.
Fishawack Health
Fishawack Health welcomes expert-led dermatology initiative FIDE to its group
Fishawack Health welcomes FIDE, an independent organization providing its clients with insight from clinical key opinion leaders in inflammatory dermatology
Fishawack Health
Rethinking immunodermatology: Patient and market insights from leading KOLs and life science leaders
In our new publication, we speak to key opinion leaders and industry experts to uncover novel strategies for commercializing immunodermatology therapies in a crowded market landscape.
Fishawack Health